A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants. Yang Y, Suhasini AN, Jiang Z, Liu N, et al. Cancer Res 2024;84:2169-2180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang Y, Suhasini AN, Jiang Z, Liu N, et al. A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants. Cancer Res 2024;84:2169-2180.
PMID: 39082679